BRETYLOL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Bretylol, and when can generic versions of Bretylol launch?
Bretylol is a drug marketed by Hospira and is included in one NDA.
The generic ingredient in BRETYLOL is bretylium tosylate. There are three drug master file entries for this compound. Additional details are available on the bretylium tosylate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BRETYLOL?
- What are the global sales for BRETYLOL?
- What is Average Wholesale Price for BRETYLOL?
Summary for BRETYLOL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 80 |
| DailyMed Link: | BRETYLOL at DailyMed |
US Patents and Regulatory Information for BRETYLOL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospira | BRETYLOL | bretylium tosylate | INJECTABLE;INJECTION | 017954-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for BRETYLOL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Hospira | BRETYLOL | bretylium tosylate | INJECTABLE;INJECTION | 017954-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
